Doreen Eastes works with Li Zhang, PhD, to investigate the pathogenesis of islet autoimmunity and antigen-specific immune interventions for treating type 1 diabetes.
She joined the Indiana Biosciences Research Institute (IBRI) as a research analyst in the IBRI’s then Single Cell Analytics Center, which was phased out in the spring of 2019 to pursue external commercialization of its diagnostic platform. She then moved to the IBRI's Pharmaceutical Biotechnology Center (PBC), where she was responsible for establishing hybridoma production capabilities and development of new and existing protein therapeutics.
Prior to the IBRI, Eastes was a research technician in the Wells Center for Pediatric Research at the Indiana University (IU) School of Medicine. She also has served as an assistant diabetes research scientist at Eli Lilly and Company. Her broad scientific experience also included research at Schering-Plough Animal Health in Mundelein, IL, Interdisciplinary Center for Cell Products and Technologies (ICCPT) in Terre Haute, IN, and at Pitman-Moore Inc., also in Terre Haute.
View Eastes' published research here.